Info: Read More
  • 中药标准品生产商,产品定制服务
  • 远志皂苷D

    Polygalacin D

    远志皂苷D
    产品编号 CFN93351
    CAS编号 66663-91-0
    分子式 = 分子量 C57H92O27 = 1209.4
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Triterpenoids
    植物来源 The roots of Polygala tenuifolia Willd
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    远志皂苷D CFN93351 66663-91-0 1mg QQ客服:2056216494
    远志皂苷D CFN93351 66663-91-0 5mg QQ客服:2056216494
    远志皂苷D CFN93351 66663-91-0 10mg QQ客服:2056216494
    远志皂苷D CFN93351 66663-91-0 20mg QQ客服:2056216494
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • University of Wisconsin-Madison (USA)
  • Universidade Federal de Goias (UFG) (Brazil)
  • Kazusa DNA Research Institute (Japan)
  • Instytut Nawozów Sztucznych w Pu?awach (Poland)
  • Aveiro University (Portugal)
  • Universiti Kebangsaan Malaysia (Malaysia)
  • Univerzita Karlova v Praze (Czech Republic)
  • Worcester Polytechnic Institute (USA)
  • Weizmann Institute of Science (Israel)
  • University of Hertfordshire (United Kingdom)
  • Molecular Biology Institute of Barcelona (IBMB)-CSIC (Spain)
  • Universiti Putra Malaysia(UPM) (Malaysia)
  • Centrum Menselijke Erfelijkheid (Belgium)
  • Florida A&M University (USA)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Molecular & Cellular Toxicology2017, 13(3):271-278
  • Cells. 2023, 12(15):1934.
  • Evid Based Complement Alternat Med.2019, 2019:2135351
  • Nutrients.2021, 13(8):2901.
  • J Nutr Biochem.2022, 107:109064.
  • Chemistry of Plant Materials.2019, 129-136
  • J Colloid Interface Sci.2024, 662:760-773.
  • PLoS One.2020, 15(2):e0220084.
  • Elife.2021, 10:e68058.
  • In Vitro Cellular & Developmental Biology - Plant2022, 58:972-988.
  • Int J Mol Sci.2021, 22(12):6466.
  • Am J Chin Med.2016, 44(8):1719-1735
  • Molecules.2023, 28(19):6767.
  • Preprints2022, 202211.0388.v1.
  • Inflammation.2022, 45(6):2529-2543.
  • bioRxiv - Biochemistry2023, 548213.
  • Food Sci Biotechnol.2023, 32(7):997-1003.
  • Cells.2021, 10(11):2919.
  • Metabolites2022, 12(6),507.
  • Ann Transl Med.2019, 7(23):731
  • Molecules2022, 27(11):3606.
  • ACS Synth Biol.2022, doi: 10.1021.
  • Curr Med Sci.2024, 44(2):355-368.
  • ...
  • 生物活性
    Description: Polygalacin D shows anti- proliferation, anti-inflammary, and hepatoprotective activities, it can inhibit the expression of lipopolysaccharide (LPS)-induced iNOS and COX-2 protein and mRNA without an appreciable cytotoxic effect on RAW 264.7 macrophages, and can suppress induction by LPS of pro-inflammatory cytokines such as prostaglandin E2 (PGE2).
    Targets: NOS | COX | PGE | NO | NF-kB
    In vitro:
    Life Sci., 2005, 76(20):2315-28.
    Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappaB activation in RAW 264.7 cells.[Pubmed: 15748625 ]
    Saponins are glycosidic compounds present in many edible and inedible plants. They exhibit potent biological activities in mammalian systems, including several beneficial effects such as anti-inflammation and immunomodulation.
    METHODS AND RESULTS:
    In this study, we investigated the effects of seven platycodin saponins on the activities of inducible nitric oxide synthase (iNOS) and cyclooxygenase II (COX-2) in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. We found that 2"-O-acetyl Polygalacin D (S1), platycodin A (S2), platycodin D (S3), and Polygalacin D (S6) inhibited LPS-induced NO production in a concentration-dependent manner. Furthermore, these compounds inhibited the expression of LPS-induced iNOS and COX-2 protein and mRNA without an appreciable cytotoxic effect on RAW 264.7 macrophages, and could suppress induction by LPS of pro-inflammatory cytokines such as prostaglandin E2 (PGE2). Treatment with these compounds of RAW 264.7 cells transfected with a reporter construct indicated a reduced level of LPS-induced nuclear factor-kappaB (NF-kappaB) activity and effectively lowered NF-kappaB binding as measured by electrophoretic mobility shift assay (EMSA). The suppression of NF-kappaB activation appears to occur through the prevention of inhibitor kappaB (IkappaB) degradation. In vivo, platycodin saponin mixture (PS) and S3 protected mice from the lethal effects of LPS. The 89% lethality induced by LPS/galactosamine was reduced to 60% and 50% when PS and S3, respectively, were administered simultaneously with LPS.
    CONCLUSIONS:
    These results suggest that the main inhibitory mechanism of the platycodin saponins may be the reduction of iNOS and COX-2 gene expression through blocking of NF-kappaB activation.
    Molecules, 2012, 17(12):14899-907.
    Two new oleanane-type triterpenoids from Platycodi Radix and anti-proliferative activity in HSC-T6 cells.[Pubmed: 23519261 ]
    Two new oleanane-type triterpenoids, named platycodonoids A and B (1, 2), together with five known saponins, including platycodin D (3), deapioplatycodin D (4), 3-O-β-D-glucopyranosyl polygalacic acid (5), 3-O-β-D-glucopyranosyl platycodigenin (6) and Polygalacin D (7), were isolated from the roots of Platycodon grandiflorum.
    METHODS AND RESULTS:
    On the basis of spectral data and chemical evidence, the structures of the new compounds were elucidated as 2β,3β,23,24-tetrahydroxy-28-nor-olean-12-en-16-one (1) and 2β,3β,23,24- tetrahydroxy-28-nor-olean-12-en-16-one-3-O-β-D-glucopyranoside (2). Compounds 1-7 were evaluated for their in vitro anti-proliferative activity against the HSC-T6 cell line.
    Oncol Rep . 2018 Apr;39(4):1702-1710.
    Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer[Pubmed: 29393481]
    Abstract Polygalacin D (PGD) is a bioactive compound isolated from Platycodon grandiflorum (Jacq.) and it has a similar structure to platycodin D, which is a well known anticancer agent. In the present study, we investigated the anti-proliferative effects of PGD using NSCLC cell lines. We evaluated the effects of PGD on proliferation, apoptosis and cell cycle arrest in A549 and H460 cells. PGD significantly induced apoptosis and nuclear condensation in both cell lines. Furthermore, PGD upregulated the cleavage of apoptotic proteins such as caspase-3, -9 and PARP. Additionally, treatment with PGD suppressed the expression of the IAP family of proteins including survivin, cIAP-1 and cIAP-2. Furthermore, PGD induced G0/G1-phase arrest in both cell lines. After treatment with PGD, the expression of TIMP-1, CDK2, cyclin A and cyclin E was reduced at the protein level. In addition, PGD blocked the PI3K/Akt pathway by inhibiting the phosphorylation of GSK3β, Akt and the expression of PI3K. Our results indicated that the anti-proliferative properties of PGD may result from the regulation of the PI3K/Akt pathway, which plays a critical role in cell survival and growth.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 0.8269 mL 4.1343 mL 8.2686 mL 16.5371 mL 20.6714 mL
    5 mM 0.1654 mL 0.8269 mL 1.6537 mL 3.3074 mL 4.1343 mL
    10 mM 0.0827 mL 0.4134 mL 0.8269 mL 1.6537 mL 2.0671 mL
    50 mM 0.0165 mL 0.0827 mL 0.1654 mL 0.3307 mL 0.4134 mL
    100 mM 0.0083 mL 0.0413 mL 0.0827 mL 0.1654 mL 0.2067 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    Platycoside E; Platycoside E CFN90786 237068-41-6 C69H112O38 = 1549.6 5mg QQ客服:1457312923
    青葙苷H; Celosin H CFN91669 1623405-28-6 C47H72O20 = 957.06 10mg QQ客服:2056216494
    青葙苷I; Celosin I CFN91061 1807732-38-2 C53H82O24 = 1103.2 10mg QQ客服:1413575084
    青葙苷J; Celosin J CFN91152 1623405-29-7 C58H90O28 = 1235.3 5mg QQ客服:215959384
    瓜子金皂苷XXXV; Polygalasaponin XXXV CFN95176 184479-28-5 C63H98O31 = 1351.5 5mg QQ客服:2056216494
    远志皂苷B; Onjisaponin B CFN90600 35906-36-6 C75H112O35 = 1573.69 5mg QQ客服:215959384
    瓜子金皂苷XXXI; Polygalasaponin XXXI CFN90728 79103-90-5 C75H112O36 = 1589.67 5mg QQ客服:3257982914
    瓜子金皂苷XLIX; Polygalasaponin XLIX CFN95117 1033593-12-2 C64H102O33 = 1399.47 10mg QQ客服:3257982914
    冬青苷XLVIII; Ilexoside XLVIII CFN91698 129095-76-7 C42H66O15 = 811.0 5mg QQ客服:2159513211
    川续断皂苷VI; 木通皂苷D; Asperosaponin VI CFN99766 39524-08-8 C47H76O18 = 929.10 20mg QQ客服:2056216494

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产